announces
-
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31,…
Read More » -
Regulatory
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
– Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to…
Read More » -
Extremities
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
Stephen Deitsch resigns from his position as Chief Financial Officer to pursue another opportunity; Kristina Wright appointed interim Chief Financial…
Read More » -
Extremities
Arthrex Commemorates 10th Anniversary of InternalBrace™ Technique
Company honors technological treatment advancements over the decade since release of the groundbreaking surgical system NAPLES, Fla., April 2, 2024 /PRNewswire/ — Arthrex, a global leader in minimally invasive…
Read More » -
Biologics
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human…
Read More » -
Financial
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Establishes Full Year 2024 Revenue Guidance of $112 Million – $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) —…
Read More » -
Financial
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
MELVILLE, N.Y., April 01, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused…
Read More » -
Financial
SANUWAVE Announces Record Q4 and FY2023 Revenue
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4…
Read More » -
Spine
Mainstay Medical Announces Publication of the First Neuromodulation Study for Low Back Pain with 5-Year Follow-Up
Groundbreaking ReActiv8-B study supports the long-term efficacy, safety and durability of ReActiv8® Restorative NeurostimulationTM for the treatment of intractable Chronic Low…
Read More » -
Financial
Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery
CARLSBAD, Calif., March 18, 2024–(BUSINESS WIRE)–Carlsmed, an AI-enabled personalized surgery Medtech company, announced today a $52.5M Series C funding round co-led…
Read More » -
Spine
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
LEWISVILLE, Texas, March 18, 2024–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that Lucas…
Read More »